Hemp was among the first plants to be harvested for its usable fibre. Although it has many commercial applications, hemp seed oil has a variety of health benefits, especially as an anti-inflammatory. Hemp seeds are eaten raw, sprout powder, ground into meal, used for baking, and even taken ask liquid (hemp milk and beer). Leaves of the hemp plant can be used in salads or pressed into juice; however, they are not quite as nutritious as the seeds.
Hemp contains 9 different amino acids and it is high in both protein and fibre. Its oil is used for its anti-aging properties.
Hemp seed oil is used to treat MS, osteoporosis, and psoriasis. Further, is has applications as an effective moisturizer, now seen throughout many commercial beauty products.
Be mindful that hemp seed oil is susceptible to oxidation and becoming rancid. To prevent the oil going off, avoid heat and light.
Please use moderation and care when using herbs and read our disclaimer
6784680
{6784680:FNFMLW7V},{6784680:4CZ68WBJ},{6784680:JAXUXLKQ},{6784680:YFJZZDW8},{6784680:VTR3QFTF},{6784680:9AVJYFDJ}
1
apa
50
default
1387
https://lae.nfa.temporary.site/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22VTR3QFTF%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hayashi%22%2C%22parsedDate%22%3A%222009-03-05%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHayashi%2C%20Y.%20%282009%2C%20March%205%29.%20In%20Drug-Leery%20Japan%2C%20Arrests%20for%20Marijuana%20Are%20on%20the%20Rise.%20%26lt%3Bi%26gt%3BWall%20Street%20Journal%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.wsj.com%5C%2Farticles%5C%2FSB123612257155123461%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.wsj.com%5C%2Farticles%5C%2FSB123612257155123461%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22newspaperArticle%22%2C%22title%22%3A%22In%20Drug-Leery%20Japan%2C%20Arrests%20for%20Marijuana%20Are%20on%20the%20Rise%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuka%22%2C%22lastName%22%3A%22Hayashi%22%7D%5D%2C%22abstractNote%22%3A%22Marijuana%20arrests%20are%20soaring%20in%20Japan%2C%20causing%20a%20public%20sensation%20in%20a%20nation%20where%20illegal-drug%20use%20is%20relatively%20rare.%22%2C%22date%22%3A%222009-03-05T04%3A59%3A00.000Z%22%2C%22section%22%3A%22World%20News%22%2C%22language%22%3A%22en-US%22%2C%22ISSN%22%3A%220099-9660%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.wsj.com%5C%2Farticles%5C%2FSB123612257155123461%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-23T04%3A46%3A53Z%22%7D%7D%2C%7B%22key%22%3A%224CZ68WBJ%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kafil%20et%20al.%22%2C%22parsedDate%22%3A%222018-11-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKafil%2C%20T.%20S.%2C%20Nguyen%2C%20T.%20M.%2C%20MacDonald%2C%20J.%20K.%2C%20%26amp%3B%20Chande%2C%20N.%20%282018%29.%20Cannabis%20for%20the%20treatment%20of%20Crohn%26%23x2019%3Bs%20disease.%20%26lt%3Bi%26gt%3BThe%20Cochrane%20Database%20of%20Systematic%20Reviews%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%20CD012853.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F14651858.CD012853.pub2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2F14651858.CD012853.pub2%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cannabis%20for%20the%20treatment%20of%20Crohn%27s%20disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tahir%20S.%22%2C%22lastName%22%3A%22Kafil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tran%20M.%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20K.%22%2C%22lastName%22%3A%22MacDonald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nilesh%22%2C%22lastName%22%3A%22Chande%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Crohn%26%23039%3Bs%20disease%20%28CD%29%20is%20a%20chronic%20immune-mediated%20condition%20of%20transmural%20inflammation%20in%20the%20gastrointestinal%20tract%2C%20associated%20with%20significant%20morbidity%20and%20decreased%20quality%20of%20life.%20The%20endocannabinoid%20system%20provides%20a%20potential%20therapeutic%20target%20for%20cannabis%20and%20cannabinoids%20and%20animal%20models%20have%20shown%20benefit%20in%20decreasing%20inflammation.%20However%2C%20there%20is%20also%20evidence%20to%20suggest%20transient%20adverse%20events%20such%20as%20weakness%2C%20dizziness%20and%20diarrhea%2C%20and%20an%20increased%20risk%20of%20surgery%20in%20people%20with%20CD%20who%20use%20cannabis.%5CnOBJECTIVES%3A%20The%20objectives%20were%20to%20assess%20the%20efficacy%20and%20safety%20of%20cannabis%20and%20cannabinoids%20for%20induction%20and%20maintenance%20of%20remission%20in%20people%20with%20CD.%5CnSEARCH%20METHODS%3A%20We%20searched%20MEDLINE%2C%20Embase%2C%20AMED%2C%20PsychINFO%2C%20the%20Cochrane%20IBD%20Group%20Specialized%20Register%2C%20CENTRAL%2C%20ClinicalTrials.Gov%2C%20and%20the%20European%20Clinical%20Trials%20Register%20up%20to%2017%20October%202018.%20We%20searched%20conference%20abstracts%2C%20references%20and%20we%20also%20contacted%20researchers%20in%20this%20field%20for%20upcoming%20publications.%5CnSELECTION%20CRITERIA%3A%20Randomized%20controlled%20trials%20comparing%20any%20form%20of%20cannabis%20or%20its%20cannabinoid%20derivatives%20%28natural%20or%20synthetic%29%20to%20placebo%20or%20an%20active%20therapy%20for%20adults%20with%20Crohn%26%23039%3Bs%20disease%20were%20included.%5CnDATA%20COLLECTION%20AND%20ANALYSIS%3A%20Two%20authors%20independently%20screened%20search%20results%2C%20extracted%20data%20and%20assessed%20bias%20using%20the%20Cochrane%20risk%20of%20bias%20tool.%20The%20primary%20outcomes%20were%20clinical%20remission%20and%20relapse.%20Remission%20is%20commonly%20defined%20as%20a%20Crohn%26%23039%3Bs%20disease%20activity%20index%20%28CDAI%29%20of%20%26lt%3B%20150.%20Relapse%20is%20defined%20as%20a%20CDAI%20%26gt%3B%20150.%20Secondary%20outcomes%20included%20clinical%20response%2C%20endoscopic%20remission%2C%20endoscopic%20improvement%2C%20histological%20improvement%2C%20quality%20of%20life%2C%20C-reactive%20protein%20%28CRP%29%20and%20fecal%20calprotectin%20measurements%2C%20adverse%20events%20%28AEs%29%2C%20serious%20AEs%2C%20withdrawal%20due%20to%20AEs%2C%20and%20cannabis%20dependence%20and%20withdrawal%20effects.%20We%20calculated%20the%20risk%20ratio%20%28RR%29%20and%20corresponding%2095%25%20confidence%20interval%20%2895%25%20CI%29%20for%20dichotomous%20outcomes.%20For%20continuous%20outcomes%2C%20we%20calculated%20the%20mean%20difference%20%28MD%29%20and%2095%25%20CI.%20Data%20were%20combined%20for%20analysis%20when%20the%20interventions%2C%20patient%20groups%20and%20outcomes%20were%20sufficiently%20similar%20%28determined%20by%20consensus%29.%20Data%20were%20analyzed%20on%20an%20intention-to-treat%20basis%20and%20the%20overall%20certainty%20of%20the%20evidence%20supporting%20the%20outcomes%20was%20evaluated%20using%20the%20GRADE%20criteria.%5CnMAIN%20RESULTS%3A%20Three%20studies%20%2893%20participants%29%20that%20assessed%20cannabis%20in%20people%20with%20active%20CD%20met%20the%20inclusion%20criteria.%20One%20ongoing%20study%20was%20also%20identified.%20Participants%20in%20two%20of%20the%20studies%20were%20adults%20with%20active%20Crohn%26%23039%3Bs%20disease%20who%20had%20failed%20at%20least%20one%20medical%20treatment.%20The%20inclusion%20criteria%20for%20the%20third%20study%20were%20unclear.%20No%20studies%20that%20assessed%20cannabis%20therapy%20in%20quiescent%20CD%20were%20identified.%20The%20studies%20were%20not%20pooled%20due%20to%20differences%20in%20the%20interventional%20drug.One%20small%20study%20%28N%20%3D%2021%29%20compared%20eight%20weeks%20of%20treatment%20with%20cannabis%20cigarettes%20containing%20115%20mg%20of%20D9-tetrahydrocannabinol%20%28THC%29%20to%20placebo%20cigarettes%20containing%20cannabis%20with%20the%20THC%20removed%20in%20participants%20with%20active%20CD.%20This%20study%20was%20rated%20as%20high%20risk%20of%20bias%20for%20blinding%20and%20other%20bias%20%28cannabis%20participants%20were%20older%20than%20placebo%29.%20The%20effects%20of%20cannabis%20on%20clinical%20remission%20were%20unclear.%20Forty-five%20per%20cent%20%285%5C%2F11%29%20of%20the%20cannabis%20group%20achieved%20clinical%20remission%20compared%20with%2010%25%20%281%5C%2F10%29%20of%20the%20placebo%20group%20%28RR%204.55%2C%2095%25%20CI%200.63%20to%2032.56%3B%20very%20low%20certainty%20evidence%29.%20A%20difference%20was%20observed%20in%20clinical%20response%20%28decrease%20in%20CDAI%20score%20of%20%26gt%3B100%20points%29%20rates.%20Ninety-one%20per%20cent%20%2810%5C%2F11%29%20of%20the%20cannabis%20group%20achieved%20a%20clinical%20response%20compared%20to%2040%25%20%284%5C%2F10%29%20of%20the%20placebo%20group%20%28RR%202.27%2C%2095%25%20CI%201.04%20to%204.97%3B%20very%20low%20certainty%20evidence%29.%20More%20AEs%20were%20observed%20in%20the%20cannabis%20cigarette%20group%20compared%20to%20placebo%20%28RR%204.09%2C%2095%25%20CI%201.15%20to%2014.57%3B%20very%20low%20certainty%20evidence%29.%20These%20AEs%20were%20considered%20to%20be%20mild%20in%20nature%20and%20included%20sleepiness%2C%20nausea%2C%20difficulty%20with%20concentration%2C%20memory%20loss%2C%20confusion%20and%20dizziness.%20This%20study%20did%20not%20report%20on%20serious%20AEs%20or%20withdrawal%20due%20to%20AEs.One%20small%20study%20%28N%20%3D%2022%29%20compared%20cannabis%20oil%20%285%25%20cannabidiol%29%20to%20placebo%20oil%20in%20people%20with%20active%20CD.%20This%20study%20was%20rated%20as%20high%20risk%20of%20bias%20for%20other%20bias%20%28cannabis%20participants%20were%20more%20likely%20than%20placebo%20participants%20to%20be%20smokers%29.%20There%20was%20no%20difference%20in%20clinical%20remission%20rates.%20Forty%20per%20cent%20%284%5C%2F10%29%20of%20cannabis%20oil%20participants%20achieved%20remission%20at%208%20weeks%20compared%20to%2033%25%20%283%5C%2F9%29%20of%20the%20placebo%20participants%20%28RR%201.20%2C%2095%25%20CI%200.36%20to%203.97%3B%20very%20low%20certainty%20evidence%29.%20There%20was%20no%20difference%20in%20the%20proportion%20of%20participants%20who%20had%20a%20serious%20adverse%20event.%20Ten%20per%20cent%20%281%5C%2F10%29%20of%20participants%20in%20the%20cannabis%20oil%20group%20had%20a%20serious%20adverse%20event%20compared%20to%2011%25%20%281%5C%2F9%29%20of%20placebo%20participants%20%28RR%200.90%2C%2095%25%20CI%200.07%20to%2012.38%2C%20very%20low%20certainty%20evidence%29.%20Both%20serious%20AEs%20were%20worsening%20Crohn%26%23039%3Bs%20disease%20that%20required%20rescue%20intervention.%20This%20study%20did%20not%20report%20on%20clinical%20response%2C%20CRP%2C%20quality%20of%20life%20or%20withdrawal%20due%20to%20AEs.One%20small%20study%20%28N%3D%2050%29%20compared%20cannabis%20oil%20%2815%25%20cannabidiol%20and%204%25%20THC%29%20to%20placebo%20in%20participants%20with%20active%20CD.%20This%20study%20was%20rated%20as%20low%20risk%20of%20bias.%20Differences%20in%20CDAI%20and%20quality%20of%20life%20scores%20measured%20by%20the%20SF-36%20instrument%20were%20observed.%20The%20mean%20quality%20of%20life%20score%20after%208%20weeks%20of%20treatment%20was%2096.3%20in%20the%20cannabis%20oil%20group%20compared%20to%2079.9%20in%20the%20placebo%20group%20%28MD%2016.40%2C%2095%25%20CI%205.72%20to%2027.08%2C%20low%20certainty%20evidence%29.%20After%208%20weeks%20of%20treatment%2C%20the%20mean%20CDAI%20score%20was118.6%20in%20the%20cannabis%20oil%20group%20compared%20to%20212.6%20in%20the%20placebo%20group%20%28MD%20-94.00%2C%2095%25CI%20-148.86%20to%20-39.14%2C%20low%20certainty%20evidence%29.%20This%20study%20did%20not%20report%20on%20clinical%20remission%2C%20clinical%20response%2C%20CRP%20or%20AEs.%5CnAUTHORS%26%23039%3B%20CONCLUSIONS%3A%20The%20effects%20of%20cannabis%20and%20cannabis%20oil%20on%20Crohn%26%23039%3Bs%20disease%20are%20uncertain.%20Thus%20no%20firm%20conclusions%20regarding%20the%20efficacy%20and%20safety%20of%20cannabis%20and%20cannabis%20oil%20in%20adults%20with%20active%20Crohn%26%23039%3Bs%20disease%20can%20be%20drawn.%20The%20effects%20of%20cannabis%20or%20cannabis%20oil%20in%20quiescent%20Crohn%26%23039%3Bs%20disease%20have%20not%20been%20investigated.%20Further%20studies%20with%20larger%20numbers%20of%20participants%20are%20required%20to%20assess%20the%20potential%20benefits%20and%20harms%20of%20cannabis%20in%20Crohn%26%23039%3Bs%20disease.%20Future%20studies%20should%20assess%20the%20effects%20of%20cannabis%20in%20people%20with%20active%20and%20quiescent%20Crohn%26%23039%3Bs%20disease.%20Different%20doses%20of%20cannabis%20and%20delivery%20modalities%20should%20be%20investigated.%22%2C%22date%22%3A%22Nov%2008%2C%202018%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2F14651858.CD012853.pub2%22%2C%22ISSN%22%3A%221469-493X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-23T04%3A46%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22JAXUXLKQ%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kis%20et%20al.%22%2C%22parsedDate%22%3A%222019-11-25%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKis%2C%20B.%2C%20Ifrim%2C%20F.%20C.%2C%20Buda%2C%20V.%2C%20Avram%2C%20S.%2C%20Pavel%2C%20I.%20Z.%2C%20Antal%2C%20D.%2C%20Paunescu%2C%20V.%2C%20Dehelean%2C%20C.%20A.%2C%20Ardelean%2C%20F.%2C%20Diaconeasa%2C%20Z.%2C%20Soica%2C%20C.%2C%20%26amp%3B%20Danciu%2C%20C.%20%282019%29.%20Cannabidiol-from%20Plant%20to%20Human%20Body%3A%20A%20Promising%20Bioactive%20Molecule%20with%20Multi-Target%20Effects%20in%20Cancer.%20%26lt%3Bi%26gt%3BInternational%20Journal%20of%20Molecular%20Sciences%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B%2823%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms20235905%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijms20235905%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cannabidiol-from%20Plant%20to%20Human%20Body%3A%20A%20Promising%20Bioactive%20Molecule%20with%20Multi-Target%20Effects%20in%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitta%22%2C%22lastName%22%3A%22Kis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feng%20Chen%22%2C%22lastName%22%3A%22Ifrim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valentina%22%2C%22lastName%22%3A%22Buda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefana%22%2C%22lastName%22%3A%22Avram%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioana%20Zinuca%22%2C%22lastName%22%3A%22Pavel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Antal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virgil%22%2C%22lastName%22%3A%22Paunescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%20Adriana%22%2C%22lastName%22%3A%22Dehelean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florina%22%2C%22lastName%22%3A%22Ardelean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zorita%22%2C%22lastName%22%3A%22Diaconeasa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Codruta%22%2C%22lastName%22%3A%22Soica%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corina%22%2C%22lastName%22%3A%22Danciu%22%7D%5D%2C%22abstractNote%22%3A%22Cannabis%20sativa%20L.%20is%20a%20plant%20long%20used%20for%20its%20textile%20fibers%2C%20seed%20oil%2C%20and%20oleoresin%20with%20medicinal%20and%20psychoactive%20properties.%20It%20is%20the%20main%20source%20of%20phytocannabinoids%2C%20with%20over%20100%20compounds%20detected%20so%20far.%20In%20recent%20years%2C%20a%20lot%20of%20attention%20has%20been%20given%20to%20the%20main%20phytochemicals%20present%20in%20Cannabis%20sativa%20L.%2C%20namely%2C%20cannabidiol%20%28CBD%29%20and%20%5Cu03949-tetrahydrocannabinol%20%28THC%29.%20Compared%20to%20THC%2C%20CBD%20has%20non-psychoactive%20effects%2C%20an%20advantage%20for%20clinical%20applications%20of%20anti-tumor%20benefits.%20The%20review%20is%20designed%20to%20provide%20an%20update%20regarding%20the%20multi-target%20effects%20of%20CBD%20in%20different%20types%20of%20cancer.%20The%20main%20focus%20is%20on%20the%20latest%20in%20vitro%20and%20in%20vivo%20studies%20that%20present%20data%20regarding%20the%20anti-proliferative%2C%20pro-apoptotic%2C%20cytotoxic%2C%20anti-invasive%2C%20anti-antiangiogenic%2C%20anti-inflammatory%2C%20and%20immunomodulatory%20properties%20of%20CBD%20together%20with%20their%20mechanisms%20of%20action.%20The%20latest%20clinical%20evidence%20of%20the%20anticancer%20effects%20of%20CBD%20is%20also%20outlined.%20Moreover%2C%20the%20main%20aspects%20of%20the%20pharmacological%20and%20toxicological%20profiles%20are%20given.%22%2C%22date%22%3A%22Nov%2025%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fijms20235905%22%2C%22ISSN%22%3A%221422-0067%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-23T04%3A46%3A32Z%22%7D%7D%2C%7B%22key%22%3A%22YFJZZDW8%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hoffenberg%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHoffenberg%2C%20E.%20J.%2C%20McWilliams%2C%20S.%2C%20Mikulich-Gilbertson%2C%20S.%2C%20Murphy%2C%20B.%2C%20Hoffenberg%2C%20A.%2C%20%26amp%3B%20Hopfer%2C%20C.%20J.%20%282019%29.%20Cannabis%20Oil%20Use%20by%20Adolescents%20and%20Young%20Adults%20With%20Inflammatory%20Bowel%20Disease.%20%26lt%3Bi%26gt%3BJournal%20of%20Pediatric%20Gastroenterology%20and%20Nutrition%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B68%26lt%3B%5C%2Fi%26gt%3B%283%29%2C%20348%26%23x2013%3B352.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMPG.0000000000002189%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FMPG.0000000000002189%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cannabis%20Oil%20Use%20by%20Adolescents%20and%20Young%20Adults%20With%20Inflammatory%20Bowel%20Disease%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20J.%22%2C%22lastName%22%3A%22Hoffenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%22%2C%22lastName%22%3A%22McWilliams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%22%2C%22lastName%22%3A%22Mikulich-Gilbertson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brittany%22%2C%22lastName%22%3A%22Murphy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Analice%22%2C%22lastName%22%3A%22Hoffenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%20J.%22%2C%22lastName%22%3A%22Hopfer%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20The%20aim%20of%20the%20study%20was%20to%20describe%20use%20of%20oral%20or%20sublingual%20cannabis%20oil%20%28CO%29%20by%20adolescent%20and%20young%20adult%20patients%20with%20inflammatory%20bowel%20disease%20%28IBD%29.%5CnMETHODS%3A%20A%20descriptive%20study%20of%20IBD%20patients%2013%20to%2023%20years%20of%20age%20seen%20between%20January%202015%20through%20December%202017%20at%20Children%26%23039%3Bs%20Hospital%20Colorado.%20Information%20obtained%20included%20chart%20abstraction%2C%20electronic%20and%20interview%20self-report%2C%20and%20serum%20cannabinoid%20levels.%20We%20compared%20CO%20users%20and%20cannabis%20non-users%20for%20clinical%20characteristics%20and%20perceptions%20of%20risk.%20Users%20of%20CO%20provided%20information%20on%20routes%2C%20patterns%2C%20motivations%2C%20and%20perceived%20benefits%20and%20problems%20with%20use.%5CnRESULTS%3A%20The%2015%20users%20and%2067%20non-users%20were%20similar%20for%20clinical%20characteristics%20and%20pain%20and%20appetite%20scores.%209%20of%2015%20%2860%25%29%20CO%20users%20had%20used%20in%20the%20past%2030%20days%2C%20an%20average%20of%2022%5Cu200a%5Cu00b1%5Cu200a9%20times%3B%20and%204%20used%20daily.%20A%20variety%20of%20strengths%20and%20CBD%3ATHC%20ratios%20were%20reported.%20Most%20common%20perceived%20effect%20of%20use%20was%20on%20sleep%20quality%2C%20nausea%2C%20and%20increase%20in%20appetite.%20Of%20the%2015%20users%2C%206%20used%20only%20CO%20and%20no%20additional%20forms%20of%20cannabis.%20Of%20these%206%20CO%20only%20users%2C%205%20reported%20a%20medical%20reason%20for%20use%2C%20most%20commonly%20to%20relieve%20pain.%5CnCONCLUSIONS%3A%20Adolescent%20and%20young%20adults%20with%20IBD%20used%20oral%20CO%20and%20many%20used%20other%20cannabis%20products%20as%20well.%20Users%20perceived%20some%20medical%20benefit.%20Care%20teams%20should%20strive%20for%20open%20communication%20about%20use%20until%20further%20information%20on%20safety%20and%20efficacy%20becomes%20available.%22%2C%22date%22%3A%2203%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FMPG.0000000000002189%22%2C%22ISSN%22%3A%221536-4801%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-23T04%3A46%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22FNFMLW7V%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Tourangeau%22%2C%22parsedDate%22%3A%222015-08-17%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BTourangeau%2C%20W.%20%282015%29.%20Re-defining%20Environmental%20Harms%3A%20Green%20Criminology%20and%20the%20State%20of%20Canada%26%23x2019%3Bs%20Hemp%20Industry.%20%26lt%3Bi%26gt%3BCanadian%20Journal%20of%20Criminology%20and%20Criminal%20Justice%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B57%26lt%3B%5C%2Fi%26gt%3B%284%29%2C%20528%26%23x2013%3B554.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3138%5C%2Fcjccj.2014.E11%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3138%5C%2Fcjccj.2014.E11%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Re-defining%20Environmental%20Harms%3A%20Green%20Criminology%20and%20the%20State%20of%20Canada%5Cu2019s%20Hemp%20Industry%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wesley%22%2C%22lastName%22%3A%22Tourangeau%22%7D%5D%2C%22abstractNote%22%3A%22Green%20criminology%20has%20been%20developing%20for%20more%20than%2020%20years%20as%20a%20field%20of%20criminological%20inquiry%20that%20grapples%20with%20defining%20and%20exploring%20environmental%20harms.%20This%20perspective%20includes%20approaches%20that%20look%20beyond%20legally%20defined%20environmental%20crimes%2C%20highlighting%20permissible%20activities%20that%20cause%20environmental%20deterioration%2C%20such%20as%20clear-cutting%20of%20forests%2C%20and%20prohibited%20activities%20that%20benefit%20the%20environment%2C%20such%20as%20pedicabs.%20Extending%20the%20criminological%20gaze%20helps%20green%20criminology%20identify%20unacknowledged%20environmental%20harms.%20The%20article%20draws%20from%20postmodernist%5C%2Fpoststructuralist%20concepts%20to%20work%20past%20merely%20defining%20actions%20as%20either%20harmful%20or%20harmless%2C%20highlighting%20the%20complexity%20of%20socio-ecological%20effects%20and%20the%20importance%20of%20extending%20the%20conceptual%20boundaries%20of%20harm.%20Canada%5Cu2019s%20experiences%20with%20industrial%20hemp%20provide%20a%20fitting%20example.%20The%20heavily%20regulated%20Canadian%20hemp%20industry%20offers%20an%20important%20case%20for%20investigating%20the%20impacts%20of%20social%20constraints%20that%20limit%20the%20industry%5Cu2019s%20capacity%20to%20benefit%20the%20environment.%20Qualitative%20interviews%20reveal%20negative%20public%20perceptions%2C%20over-restrictive%20regulatory%20requirements%2C%20and%20insufficient%20technological%20capabilities%20as%20important%20obstacles%20to%20a%20fuller%20realization%20of%20hemp%5Cu2019s%20environmental%20benefits.%20Informed%20by%20constitutive%20criminology%2C%20chaos%20criminology%2C%20and%20Halsey%5Cu2019s%20important%20critique%2C%20the%20article%20adds%20to%20postmodernist%5C%2Fpoststructuralist%20developments%20in%20green%20criminology.%22%2C%22date%22%3A%22August%2017%2C%202015%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3138%5C%2Fcjccj.2014.E11%22%2C%22ISSN%22%3A%221707-7753%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Futpjournals.press%5C%2Fdoi%5C%2F10.3138%5C%2Fcjccj.2014.E11%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-23T04%3A29%3A50Z%22%7D%7D%2C%7B%22key%22%3A%229AVJYFDJ%22%2C%22library%22%3A%7B%22id%22%3A6784680%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kirschmann%2C%20J.%2C%20%26%20Inc.%22%2C%22parsedDate%22%3A%222006%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKirschmann%2C%20J.%2C%20%26amp%3B%20Inc.%20%282006%29.%20%26lt%3Bi%26gt%3BNutrition%20Almanac%26lt%3B%5C%2Fi%26gt%3B%20%286th%20ed.%29.%20McGraw%20Hill%20Publishing.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22book%22%2C%22title%22%3A%22Nutrition%20Almanac%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22Kirschmann%2C%20J.%2C%20%26%20Inc.%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222006%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22U8LU2X8Y%22%5D%2C%22dateModified%22%3A%222020-08-10T09%3A50%3A47Z%22%7D%7D%5D%7D
Hayashi, Y. (2009, March 5). In Drug-Leery Japan, Arrests for Marijuana Are on the Rise. Wall Street Journal. https://www.wsj.com/articles/SB123612257155123461
Kafil, T. S., Nguyen, T. M., MacDonald, J. K., & Chande, N. (2018). Cannabis for the treatment of Crohn’s disease. The Cochrane Database of Systematic Reviews, 11, CD012853. https://doi.org/10.1002/14651858.CD012853.pub2
Kis, B., Ifrim, F. C., Buda, V., Avram, S., Pavel, I. Z., Antal, D., Paunescu, V., Dehelean, C. A., Ardelean, F., Diaconeasa, Z., Soica, C., & Danciu, C. (2019). Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer. International Journal of Molecular Sciences, 20(23). https://doi.org/10.3390/ijms20235905
Hoffenberg, E. J., McWilliams, S., Mikulich-Gilbertson, S., Murphy, B., Hoffenberg, A., & Hopfer, C. J. (2019). Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition, 68(3), 348–352. https://doi.org/10.1097/MPG.0000000000002189
Tourangeau, W. (2015). Re-defining Environmental Harms: Green Criminology and the State of Canada’s Hemp Industry. Canadian Journal of Criminology and Criminal Justice, 57(4), 528–554. https://doi.org/10.3138/cjccj.2014.E11
Kirschmann, J., & Inc. (2006). Nutrition Almanac (6th ed.). McGraw Hill Publishing.